FDA Approves Benznidazole, First US Drug for Chagas Disease FDA Approves Benznidazole, First US Drug for Chagas Disease
Benznidazole is indicated for treatment of children aged 2 to 12 years with Chagas disease.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 29, 2017 Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news
FDA approves first U.S. treatment for Chagas disease
The U.S. Food and Drug Administration today granted accelerated approval to benznidazole for use in children ages 2 to 12 years old with Chagas disease. It is the first treatment approved in the United States for the treatment of Chagas disease. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 29, 2017 Category: American Health Source Type: news
FDA Approves Benznidazole as First U.S. Treatment for Chagas Disease
August 29, 2017 -- The U.S. Food and Drug Administration today granted accelerated approval to benznidazole for use in children ages 2 to 12 years old with Chagas disease. It is the first treatment approved in the United States for the treatment of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 29, 2017 Category: Drugs & Pharmacology Source Type: news
Pharma bad boy Martin Shkreli is gone, but 2 companies spar over drug he snagged
"Pharma bro" Shkreli brought the Chagas disease drug to KaloBios Pharmaceuticals, but a lawsuit claims it has cost more to develop the drug than was represented. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 4, 2017 Category: Health Management Authors: Ron Leuty Source Type: news
Pharma bad boy Martin Shkreli is gone, but 2 companies spar over drug he snagged
"Pharma bro" Shkreli brought the Chagas disease drug to KaloBios Pharmaceuticals, but a lawsuit claims it has cost more to develop the drug than was represented. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 4, 2017 Category: Biotechnology Authors: Ron Leuty Source Type: news
Pharma bad boy Martin Shkreli is gone, but 2 companies spar over drug he snagged
"Pharma bro" Shkreli brought the Chagas disease drug to KaloBios Pharmaceuticals, but a lawsuit claims it has cost more to develop the drug than was represented. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 4, 2017 Category: Health Management Authors: Ron Leuty Source Type: news
Pharma bad boy Martin Shkreli is gone, but 2 companies spar over drug he snagged
"Pharma bro" Shkreli brought the Chagas disease drug to KaloBios Pharmaceuticals, but a lawsuit claims it has cost more to develop the drug than was represented. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 4, 2017 Category: Biotechnology Authors: Ron Leuty Source Type: news
Chagas Disease in the United States: Improving Patient Diagnosis and Treatment
September 14, 2017 Bronx, NY.(Montefiore Albert Einstein College of Medicine) (Source: PHPartners.org)
Source: PHPartners.org - August 2, 2017 Category: International Medicine & Public Health Source Type: news
UTEP Scientists awarded patent for Chagas disease vaccine
(The University of Texas at El Paso) A pair of scientists at The University of Texas at El Paso is one step closer to developing the first ever clinical Chagas disease vaccine.Researchers Rosa Maldonado, Ph.D., and Igor Almeida, Ph.D., both faculty in the Department of Biological Sciences, recently were granted a patent for " Mucin-Associated Surface Protein As Vaccine Against Chagas Disease. " (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 22, 2017 Category: Infectious Diseases Source Type: news
Autochthonous Transmission of Trypanosoma cruzi to Humans Autochthonous Transmission of Trypanosoma cruzi to Humans
What do we currently know about the autochthonous transmission of Chagas disease caused by T cruzi in the United States?Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 29, 2017 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news
Increased Mortality in Blood Donors Positive for Chagas Disease Increased Mortality in Blood Donors Positive for Chagas Disease
Blood donors seropositive for Chagas disease, a result of infection with Trypanosoma cruzi, have a risk of death more than twice as high as that of similar seronegative donors, according to a death certificate linkage study from Brazil.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - May 22, 2017 Category: Pathology Tags: Infectious Diseases News Source Type: news
Deaths from Chagas disease under-reported
Chagas disease, affecting millions of people in Central and South America, is classified as one of the 17 most important neglected diseases by the World Health Organization. Now, researchers have found that even the non-symptomatic stage of Chagas infection, which can last for many years, more than doubles a person ' s risk of death. The new study also concludes that deaths from Chagas have likely been under-reported in the past. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 18, 2017 Category: Science Source Type: news
Deaths from Chagas disease under-reported
(PLOS) Chagas disease, affecting millions of people in Central and South America, is classified as one of the 17 most important neglected diseases by the World Health Organization. Now, researchers have found that even the non-symptomatic stage of Chagas infection, which can last for many years, more than doubles a person's risk of death. The new study, published in PLOS Neglected Tropical Diseases, also concludes that deaths from Chagas have likely been under-reported in the past. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 18, 2017 Category: Infectious Diseases Source Type: news
Merck partners with University of California, San Diego (UCSD) to fight Neglected Tropical Diseases
Merck, a leading science and technology company, today announced that it has agreed with the University of California, San Diego (UCSD) to share compounds under the WIPO Re:Search open innovation umbrella, thereby deepening its efforts in the fight against Neglected Tropical Diseases (NTDs) to identify potential cures for leishmaniasis, Chagas disease (American trypanosomiasis) and human African trypanosomiasis (HAT, sleeping sickness). (Source: World Pharma News)
Source: World Pharma News - April 20, 2017 Category: Pharmaceuticals Tags: Featured Merck Group Business and Industry Source Type: news
Chagas Disease Presents Public Health Challenge in the U.S.
Without early treatment, Chagas disease can cause heart failure (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - April 20, 2017 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Infections, Internal Medicine, Nursing, Pathology, Pulmonology, Institutional, Source Type: news
